Skip to main navigation

Beam - Top Menu

About Us
Our Science
Our Portfolio
Investor Center
Careers
Contact

Investor Center

Investors & Media

Overview
Press Releases
Events & Presentations
Publications
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Analyst Coverage
Corporate Governance
Investor FAQs
Contact Us

Stockholder Tools

Print Page
RSS Feeds
Share Page
Email Alerts

Press Releases

Press Releases

Year

February 11, 2020

Beam Therapeutics Announces Multiple Scientific Advances in its Base Editing Technology Platforms

New Research Describes Novel Base Editors with Enhanced Editing Efficiency, Specificity, and Targeting Range CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 11, 2020-- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today

Read More

February 5, 2020

Beam Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 5, 2020-- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering of 10,588,236 shares of common stock at a public offering price

Read More

January 24, 2020

Beam Therapeutics Promotes Giuseppe Ciaramella, Ph.D., to President and Chief Scientific Officer

CAMBRIDGE, Mass., January 24, 2020 — Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the promotion of chief scientific officer Giuseppe “Pino” Ciaramella, Ph.D., to president. Dr.

Read More

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 13 of 13

Investors & Media

Overview
Press Releases
Events & Presentations
Publications
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Analyst Coverage
Corporate Governance
Investor FAQs
Contact Us

Stockholder Tools

Print Page
RSS Feeds
Share Page
Email Alerts

Beam - Top Menu

About Us
Our Science
Our Portfolio
Investor Center
Careers
Contact

Facebook
Twitter
LinkedIn